Dr. Melissa A Reimers, M.D.
Claim this profileWashington University School of Medicine
Studies Kidney Cancer
Studies Renal Cell Carcinoma
16 reported clinical trials
25 drugs studied
Area of expertise
1Kidney Cancer
Stage IV
Stage III
TFE-3/B translocation positive
2Renal Cell Carcinoma
Stage IV
Stage III
TFE-3/B translocation positive
Affiliated Hospitals
Clinical Trials Melissa A Reimers, M.D. is currently running
Cabozantinib +/− Atezolizumab
for Advanced Kidney Cancer
This phase II trial compares the effect of atezolizumab in combination with usual treatment with cabozantinib to cabozantinib alone in patients with papillary renal cell carcinoma that has spread from where it first started (primary site) to other places in the body (metastatic). Papillary renal cell carcinoma (PRCC) is a type of kidney cancer that forms in the lining of the tiny tubes in the kidney that return filtered substances that the body needs back to the blood and remove extra fluid and waste as urine. Most papillary tumors look like long, thin finger-like growths under a microscope. It is also called papillary kidney cancer or PRCC. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the tumor and may interfere with the ability of tumor cells to grow and spread. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals tumor cells to multiply and may also prevent the growth of new blood vessels that tumors need to grow. By these actions it may help slow or stop the spread of tumor cells. Combination therapy with atezolizumab and cabozantinib may shrink the tumor and allow a longer survival time in patients with metastatic renal cell carcinoma.
Recruiting1 award Phase 230 criteria
Personalized Cancer Vaccine
for Bladder Cancer
This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular residual disease. The hypothesis of the trial is that synthetic long peptide personalized cancer vaccines will be safe and capable of generating measurable neoantigen-specific T-cell responses enabling ctDNA clearance. The personalized cancer vaccines are composed of synthetic long peptides corresponding to prioritized cancer neoantigens and will be co-administered with poly-ICLC.
Recruiting1 award Phase 17 criteria
More about Melissa A Reimers, M.D.
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Melissa A Reimers, M.D. has experience with
- Nivolumab
- Cabozantinib
- Pembrolizumab
- Atezolizumab
- Ipilimumab
- Avelumab
Breakdown of trials Melissa A Reimers, M.D. has run
Kidney Cancer
Renal Cell Carcinoma
Bladder Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melissa A Reimers, M.D. specialize in?
Melissa A Reimers, M.D. focuses on Kidney Cancer and Renal Cell Carcinoma. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are Stage III.
Is Melissa A Reimers, M.D. currently recruiting for clinical trials?
Yes, Melissa A Reimers, M.D. is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Melissa A Reimers, M.D. has studied deeply?
Yes, Melissa A Reimers, M.D. has studied treatments such as Nivolumab, Cabozantinib, Pembrolizumab.
What is the best way to schedule an appointment with Melissa A Reimers, M.D.?
Apply for one of the trials that Melissa A Reimers, M.D. is conducting.
What is the office address of Melissa A Reimers, M.D.?
The office of Melissa A Reimers, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.